bacteria news from FierceBioResearcher
News
Super-resistant soil bacteria can thrive on antibiotics
People, rainfall, biodiversity breed new diseases
U.S. pipeline bone dry for new antibiotics
Concerns grow as biohazard research field booms
Vaccine offers approach to blocking infections
Synthetic biology spawns fresh approach to antibiotics
New compounds in works for tuberculosis
There's new evidence to support the theory that the enzyme protein kinase G offers a promising target in the fight against tuberculosis. The enzyme is secreted by the microbe that triggers TB and is believed to provide essential protection for the bug from the host's immune system, which tracks down and kills most pathogens. Scientists say they have a compound that can block the protein, but were worried about interfering with the action of other proteins also secreted by the microbe. …
Read more...Targets found for antibiotic development
Researchers at the University of Alabama at Birmingham have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance. In findings published online in two complementary papers in Nature, the research team describes the differences in an enzyme called RNA polymerase in bacterial cells as opposed to human cells. These differences provide potential new targets for drug design.
"Knowing how RNA …
Read more...ALSO NOTED: Federal audits provoke researchers' fears; Viralytics studies effects of virus on cancer;
Stem Cell Research
Scientists are using stem cells to treat incontinence. Report
Fear of federal audits has inspired researchers in Boston to mark each piece of lab equipment that is approved for use on embryonic stem cell projects. Report
Teng Ma, an …
Read more...Bacteria may help treat depression
An experimental cancer therapy may help point the way to a new treatment for clinical depression. The approach was inspired by work done by Dr. Mary O'Brien at the Royal Marsden Hospital in London, who injected lung cancer victims with Mycobacterium vaccae, a harmless version of bacteria that causes tuberculosis and leprosy. After the therapy was injected, the physician noted not only fewer symptoms of cancer, but an improvement in emotional health as well. Researchers followed …
Read more...Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight

